Pittsburgh, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION, founded in 1984, is a mid-sized nonprofit in the Health Care sector that reported $63.5M in total revenue in fiscal year 2024. Revenue decreased 17% compared to the prior year.
The mission of Magee-Womens Research Institute and Foundation is to advance scientific knowledge in the fields of reproductive biology and women's health; translate this knowledge into improved health for women and infants; train current and future scholars of reproductive sciences and women's health; and foster community investment and involvement in women's health.
Magee-Womens Research Institute (MWRI) is one of the largest research institutes worldwide devoted exclusively to reproductive sciences and women's health research. MWRI is making discoveries and...
Magee-Womens Research Institute (MWRI) is one of the largest research institutes worldwide devoted exclusively to reproductive sciences and women's health research. MWRI is making discoveries and advancing knowledge in many areas affecting women including: reproductive biology and development, female cancer genomics and personalized therapies, HIV immunization and prevention, fertility preservation, and pelvic floor research. Through our revolutionary 9-90TM research, we focus on how pregnancy and fetal development can affect health and disease prevention for future generations. We firmly believe that new insights into the role of early human development in defining short- and long-term health and wellness will transform our understanding of disease development, treatment and prevention for future generations. Researchers concentrate on seven key areas of discovery: reproductive endocrinology and infertility (including ovarian biology, female and male germ cell development, infertility and restoration of fertility); reproductive development (including reproductive development, stem cell biology, germ cell development and differentiation and microbiome and development); pregnancy and newborn medicine (including prenatal genetics, feto-placental development, preterm birth, preeclampsia, newborn medicine); gynecology (including family planning, benign gynecological disorders, urogynecology and pelvic floor dysfunction); infectious diseases (including HIV and vaginal microbicides, reproductive tract infections, pharmaceutics and drug delivery); women's cancers (reproductive tract cancers); and women's wellness and health services outcomes (including patient-provider communication, substance use disorders, behavioral health and alternative medicine). Considering our depth and breadth, MWRI strives to advance scientific discovery and translate the results of scientific research into knowledge pertinent to women's health. To ensure the future of women's health research, MWRI has established educational programs at all levels of academic development, including opportunities for faculty and postdoctoral scholars as well as graduate and medical students, college students and high school students. MWRI hosts the Magee-Womens Research Summit, an international conference of physicians, researchers and corporate leaders focused on women's health. The centerpiece of the summit is the award of a $1 million prize for collaborative and transformative research within the reproductive sciences. Dedicated to solving real-world problems and improving lives today and for future generations as well as to coaching the next generation of scientists, MWRI is committed to a better, healthier world in which women's health has the scientific prominence and cultural status it deserves.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $63,537,877 | $76,168,361 | -0.2% |
| Expenses | $64,925,788 | $75,569,645 | -0.1% |
| Net Income | $-1,387,911 | $598,716 | -3.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Michael Annichine | CEO | 40 |
Officer
Director
|
$590,079 | $61,105 | $651,184 |
| Yoel Sadovsky | Principal Investigator | 40 |
Highest
|
$552,230 | $85,255 | $637,485 |
| Gerald Schatten | Principal Investigator | 40 |
Highest
|
$404,439 | $61,796 | $466,235 |
| Sharon Hillier | Principal Investigator | 40 |
Highest
|
$369,392 | $45,857 | $415,249 |
| Kyle Orwig | Principal Investigator | 40 |
Highest
|
$340,990 | $48,030 | $389,020 |
| Lisa Rohan | Principal Investigator | 40 |
Highest
|
$281,750 | $57,691 | $339,441 |
| Pamela Moalli | Interim Executive Director/Principal Investigator | 40 |
Officer
Director
|
$236,976 | $46,979 | $283,955 |
| Theresa Bone | Vice Chair | 2.5 |
Officer
Director
|
$0 | $0 | $0 |
| Robert Edwards | Director | 1 |
Director
|
$0 | $0 | $0 |
| Joan Ellenbogen | Director | 1 |
Director
|
$0 | $0 | $0 |
| Margaret Joy | Director | 1 |
Director
|
$0 | $0 | $0 |
| William Pietragallo | Director | 1 |
Director
|
$0 | $0 | $0 |
| W Scott Sanford | Director | 1 |
Director
|
$0 | $0 | $0 |
| Richard Beigi | Director | 1 |
Director
|
$0 | $0 | $0 |
| Tony Lacenere | Director | 1 |
Director
|
$0 | $0 | $0 |
| Mary Richter | Director | 1 |
Director
|
$0 | $0 | $0 |
| Fern Schwartz | Director | 1 |
Director
|
$0 | $0 | $0 |
| Margaret Archinaco | Director | 1 |
Director
|
$0 | $0 | $0 |
| Anantha Shekhar | Director | 1 |
Director
|
$0 | $0 | $0 |
| David Spigelmyer | Director | 1 |
Director
|
$0 | $0 | $0 |
| Margot Bingham | Director | 1 |
Director
|
$0 | $0 | $0 |
| Carrie Coghill | Director | 1 |
Director
|
$0 | $0 | $0 |
| Kelly R Gray | Chair | 2.5 |
Officer
Director
|
$0 | $0 | $0 |
| Jason Harrison | Treasurer | 2.5 |
Officer
Director
|
$0 | $0 | $0 |
| Susan McGalla | Secretary | 2.5 |
Officer
Director
|
$0 | $0 | $0 |
| Nicole Donnellan | Director | 1 |
Director
|
$0 | $0 | $0 |
| Olivia Brinker | Director | 1 |
Director
|
$0 | $0 | $0 |
| Sheila Escovedo | Director | 1 |
Director
|
$0 | $0 | $0 |
| Deborah Murphy | Director | 1 |
Director
|
$0 | $0 | $0 |
| Carli Siger | Director | 1 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $63,537,877 | $64,925,788 | $95,797,947 | $-1,387,911 |
| 2024 | $76,168,361 | $75,569,645 | $101,671,185 | $598,716 |
| 2023 | $68,748,529 | $71,943,893 | $103,774,815 | $-3,195,364 |
| 2022 | $58,233,606 | $58,125,801 | $105,422,061 | $107,805 |
| 2021 | $54,766,122 | $55,770,823 | $116,698,693 | $-1,004,701 |
| 2020 | $80,690,649 | $57,473,228 | $107,651,082 | $23,217,421 |
| 2019 | $56,365,617 | $58,912,753 | $91,024,407 | $-2,547,136 |
| 2018 | $61,679,185 | $61,030,858 | $97,336,356 | $648,327 |
Compare MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION with other nonprofits in Pennsylvania and across the country.